微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.48% | 69.7% | 67.79% | 19/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 2.67% | 138.39% | 55.23% | 18/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.72% | 26.47% | 50.88% | 15/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 1.14% | -27.85% | -56.82% | 35/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 2.64% | 2.33% | 135.71% | 36/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 1.12% | 143.48% | -17.65% | 33/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1.36% | -10.53% | -13.92% | 28/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 1.58% | -61.08% | -38.76% | 33/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 2.58% | -56.71% | 460.87% | 35/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 0.46% | -72.62% | -69.74% | 37/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 1.52% | -7.32% | -62.56% | 25/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 4.06% | 77.29% | -31.88% | 35/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 5.96% | 33.63% | 254.76% | 24/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 1.68% | -19.62% | 2.44% | 32/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 1.64% | 217.99% | -28.38% | 21/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 2.29% | 420.45% | -48.65% | 38/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 4.46% | 230.37% | 113.4% | 20/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 2.09% | 553.13% | 250.36% | 25/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -1.39% | -521.21% | -415.91% | 25/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 0.44% | -53.68% | -67.41% | 39/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 1.35% | -10.6% | 321.88% | 24/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 0.32% | -73.11% | -3.03% | 26/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 0.33% | -72.5% | -65.26% | 23/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 0.95% | 115.03% | -37.09% | 37/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 1.51% | 369.64% | 26.89% | 24/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 1.19% | 1587.5% | -0.83% | 27/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.2% | 273.91% | 118.99% | 19/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | -6.32% | -459.29% | -1028.57% | 39/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | -0.56% | -183.58% | -600% | 25/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | -0.08% | 87.5% | 88.41% | 28/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | -0.69% | -1825% | 38.94% | 20/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | -1.13% | -116.97% | -268.66% | 29/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 0.67% | -86.35% | 204.69% | 17/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | -0.64% | -115.24% | -1700% | 20/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 0.04% | 100% | -99.4% | 16/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 6.66% | -62.92% | 35.64% | 23/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 4.91% | -38.24% | 16.9% | 13/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 4.2% | 2% | 20900% | 8/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 0.02% | 2% | -99.89% | 14/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |